News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Dispatches from Bio Digital 2021
Biotech, Mogrify, recently closed a Series A financing of US$17m, bringing the total raised to US$33m in the round, with the investment set to support the advancement of the company’s immuno-oncology and ophthalmology programs.
German company, CureVac, says it is in ongoing dialogue with the European Medicines Agency (EMA) and is continuing regulatory submissions on its first-generation mRNA COVID-19 vaccine candidate, CVnCoV.
After the success of COVID-19 mRNA vaccines, the company takes the decision as part of a ‘long-term play’ to target diseases beyond the pandemic.
The biotech invests in a new facility that will assemble and package vials and syringes for its portfolio of products.